Ductal intraepithelial neoplasia (IDH, AIDH and DCIS)

Breast Cancer

Volumn 7, Issue 4, 2000, Pages 315-320

  Tavassoli, Fattaneh A ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Ductal; Hyperplasia; Intraepithelial; Neoplasia

Indexed keywords

ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; CLASSIFICATION; FEMALE; HUMAN; PAGET NIPPLE DISEASE; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS;

EID: 0034565588     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966397     Document Type: Review

References (30)

1. Eruster VL, Barclay J, Kerlikowski K, et al: Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Int Med 160:953-958, 2000 (Pubitemid 30191923)
2. Page DL, VanderZwaag R, Rogers LW, et al: Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055-1063, 1978. (Pubitemid 9042096)
3. Page DL, Dupont WD, Rogers LW, et al: Atypical hyperplastic lesions of the female breast: A long term follow-up study. Cancer 55:2698-2708, 1985 (Pubitemid 15092160)
4. Tavassoli FA, Norris HJ: A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518, 1990.
5. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985. (Pubitemid 15192861)
6. Page DL, Dupont WD, Rogers LW, et al: Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49:751-758, 1982. (Pubitemid 12165434)
7. Rosai K: Borderline epithelial lesions of the breast. Am J Surg Pathol 15:209-221,1991
8. Schnitt SJ, Connolly J, Tavassoli FA: Interobserver reproducibility in the diagnosis of ductal proliferative lesions using standardized criteria. Am J Surg Pathol 16:1133-1143, 1992. (Pubitemid 23004420)
9. Palazzo J, Hyslop T: Hyperplasfic ductal and lobular lesions and carcinoma in situ of the breast: Reproducibility of current diagnostic criteria among community and academic based pathologists. Breast J 4:230-237, 1998. (Pubitemid 28367187)
10. Carter CL, Corle DK, Micozzi MS, et al: A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467-477,1988.
11. London SJ, Connolly JL, Schnitt SJ, et al: A prospective study of benign breast disease and the risk of breast cancer. J Am A 267:941-944, 1992.
12. Marshall LM, Hunter D J, Connolly JL, et al: Risk of breast cancer associated with atypical hyperplasia of lobular or ductal types. Cancer Epidemiol Biomarkers Prey 6:297-301, 1997. (Pubitemid 27204018)
13. McDivitt RW, Stevens JA, Lee NC, et al: Histologic types of benign breast disease and the risk for breast cancer. Cancer 69:1408-1414, 1992.
14. Palli D, Rosselli TM, Simoncini R, et al: Benign breast disease and breast cancer: a case control study in a cohort in Italy. Int J Cancer 47:703-706,1991.
15. Fitzgibbons PL, Henson DE, Hutter RV: Benign breast changes and the risk for subsequent breast cancer. An update of the 1985 consensus statement. Arch Pathol Lab Med 122:1053-1055, 1998. (Pubitemid 29009396)
16. Tavassoli F: Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140-145, 1998.
17. Tavassoli FA: Mammary intraepithelial neoplasia. Breast Journal 3:48-58, 1997.
18. Haagensen CD, Lane N, Lattes R, et al: Lobular neoplasia ( so-called lobular carcinoma in situ) of the breast. Cancer 1942:373, 1978.
19. Lakhani S, Collins N, Stratton M, et al: Atypical ductal hyperplasia of the breast: Clonal proliferation exhibiting loss of heterozygosity on chromosome 16q and 17p. J Clin Pathol48:611-615, 1995.
20. Noguchi S, Aihara T, Koyama H, et al: Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction. Can Res 54:1849-1853,1994. (Pubitemid 24116198)
21. O'Connell P, Pekkel V, Fuqua SAW, et al: Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90:697-703, 1998. (Pubitemid 28222144)
22. Moinfar F, Man Y-G, Bratthauer GL, et al: A genetic abnormality in ductal intraepithelial neoplasia of the flat type (''clinging carcinoma in situ") of the breast. Cancer 88:2072-2081, 2000. (Pubitemid 30233209)
23. Millis RR, Barnes DM, Lampejo OT, et al: Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34:548-553, 1998. (Pubitemid 28179353)
24. Lininger RA, Fujii H, Man YG, et al: Comparison of loss of heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod Pathol 11:1151-1159,1998. (Pubitemid 29009321)
25. Waldman FM, DeVries S, Chew KL, et al: Chromosomal alterations in ductal carcinoma in situ and their in situ recurrences. JNCI92:313-320, 2000. (Pubitemid 30117734)
26. Ohtake T, Abe R, Kimijima I, et al: Intraductal extension of primary invasive breast carcinoma treated by breast conserving surgery: Computer graphic three dimensional reconstruction of the mammary duct lobular systems. Cancer 76:32-45, 1995.
27. Ohuchi N: Breast-conserving surgery for invasive cancer: A principle based on segmental anatomy. Tohoku J Exp Med 188:103-118, 1999.
28. Ohuchi N, Furuta A, Mori S: Management of ductal carcinoma in situ with nipple discharge: Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast conserving surgery. Cancer 74:1294-1302, 1994. (Pubitemid 24301783)
29. Fisher B, Dignam J, Tan-Chiu E, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17. Intraductal carcinoma. Cancer86:429, 1999.
30. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999. (Pubitemid 29271743)